Correlation Between Morgan Stanley and Evaluator Aggressive

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Evaluator Aggressive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Evaluator Aggressive into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Pathway and Evaluator Aggressive Rms, you can compare the effects of market volatilities on Morgan Stanley and Evaluator Aggressive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Evaluator Aggressive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Evaluator Aggressive.

Diversification Opportunities for Morgan Stanley and Evaluator Aggressive

0.97

Correlation Coefficient

Morgan Stanley  Evaluator Aggressive

Almost no diversification

The 3 months correlation between Morgan and Evaluator is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Pathway and Evaluator Aggressive Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Aggressive Rms and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Pathway are associated (or correlated) with Evaluator Aggressive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Aggressive Rms has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Evaluator Aggressive go up and down completely randomly.

Pair Corralation between Morgan Stanley and Evaluator Aggressive

Assuming the 90 days horizon Morgan Stanley is expected to generate 3.98 times less return on investment than Evaluator Aggressive. But when comparing it to its historical volatility, Morgan Stanley Pathway is 3.73 times less risky than Evaluator Aggressive. It trades about 0.23 of its potential returns per unit of risk. Evaluator Aggressive Rms is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  1,392  in Evaluator Aggressive Rms on May 1, 2025 and sell it today you would earn a total of  74.00  from holding Evaluator Aggressive Rms or generate 5.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Morgan Stanley Pathway  vs.  Evaluator Aggressive Rms

Morgan Stanley Pathway

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Pathway are ranked lower than 19 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Morgan Stanley is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Evaluator Aggressive Rms

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Evaluator Aggressive Rms are ranked lower than 22 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Evaluator Aggressive may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Morgan Stanley and Evaluator Aggressive

The main advantage of trading using opposite Morgan Stanley and Evaluator Aggressive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Evaluator Aggressive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Aggressive will offset losses from the drop in Evaluator Aggressive's long position.

The idea behind Morgan Stanley Pathway and Evaluator Aggressive Rms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.